Anti-CD20 monoclonal antibody (Rituximab) treatment for Epstein-Barr virus-associated, B-cell lymphoproliferative disease in pediatric liver transplant rec... CONCLUSIONS: Rituximab therapy is an interesting approach for children with early EBV-associated PTLD after liver transplantation. It does not preve...
Rituximab is a monoclonal antibody against CD20 that was developed for the treatment of relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL). Recent ... F Atzeni,A Doria,T Maurizio,... - 《Autoimmunity Reviews》 被引量: 72发表: 2007年 Association of MHC and rheumatoid arthritis: Wh...
Drugs.comprovides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex (updated...
RIABNI is a CD20-directed cytolytic antibody indicated for the treatment of: Rheumatoid Arthritis (RA) in combination with methotrexate in adult patients with moderately-to severely active RA who have inadequate response to one or more TNF antagonist therapies.Thank...
While plasma exchange is a mainstay in the treatment of TTP, increased use of rituximab, an antibody against CD20, has proved helpful in the treatment of patients with exacerbations and relapses. The next generation of drugs focuses on using recombinant ADAMTS13 and molecules that block the ...
Development of the chimeric mouse antihuman CD20 antibody, Rituximab, presented a notable advance in the treatment of patients with non-Hodgkin's lymphoma ... A. Sibai a,K. Elamri b,D. Barbier a,... - 《Cancer Research》 被引量: 809发表: 2001年 A modified zonal index and its physical...
The FLIPI2 was designed more recently to separate patients with significantly different hazard ratios for progression/relapse in the era of anti-CD20 monoclonal antibody treatments. Gene profile studies have shown that the prognosis of FL is mainly related to the type, number, and activation of ...
aRituximab (trade names Rituxan, MabThera and Zytux) is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. Rituximab (商标Rituxan、MabThera和Zytux) 是一个虚构单克抗体反对蛋白质CD20,在免疫系统b细胞表面主要被找到。 [...
aan anti-CD20 chimeric monoclonal antibody anti-CD20虚构单克抗体[translate] a使用建议: 预先湿毛后直接使用,充分揉搓按摩皮毛后冲净吹干即可。若搭配使用本公司其它功能性产品更具功效。勿直接接触眼睛,若不慎接触请以清水冲洗。 The use suggested that, The wet wool directly uses after in advance, after ru...
The drug used in the treatment of rheumatoid arthritis, Anakinra, works by which means? a. T-cell co-stimulation modulator b. Interleukin-1 receptor antagonist c. Anti-CD20 B-cell depleter d. As an antibody against TNFa Assume that you isolated...